JPMorgan advises investors to take a long position in Kyndryl (KD) and a short position in DXC Technology (DXC), citing Kyndryl’s strong growth potential and DXC’s ongoing challenges. The firm highlights Kyndryl’s structural advantages, including impressive profitability and revenue growth since its spin-off from IBM, while DXC struggles with a declining legacy business and turnaround plans.